SCHEMBL21240025

SCHEMBL21240025

CC(O)(Cc1ccc(Cl)cc1)C1CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.50
SLC6A2 P23975 1/20 0.50
HTR2A P28223 1/20 0.50
HRH1 P35367 1/20 0.50
HTR2B P41595 1/20 0.50
CHRNA4 P43681 1/20 0.50
SLC6A3 Q01959 1/20 0.50
LMNA P02545 3/20 0.45
ALDH1A1 P00352 1/20 0.45
MAPT P10636 1/20 0.45
KCNH2 Q12809 1/20 0.45
CYP3A4 P08684 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
NFKB1 P19838 1/20 0.43
CYP2C19 P33261 1/20 0.43
PMP22 Q01453 1/20 0.42
NLRP3 Q96P20 1/20 0.42
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25043591 0.81 SLC6A2 (0.47) SLC6A2LMNAALDH1A1MAPTCYP3A4
SCHEMBL5873468 0.76 SLC6A4 (0.61) SLC6A4SLC6A2HTR2AHRH1HTR2B
SCHEMBL25971519 0.74 SLC6A2 (0.44) SLC6A2HRH1LMNAKCNH2CYP3A4
SCHEMBL11670635 0.74 SLC6A4 (0.59) SLC6A4SLC6A2HTR2AHRH1HTR2B
SCHEMBL19030653 0.74 CXCR3 (0.39) HTR2AHTR2BKMT2A
SCHEMBL21177760 0.72 SLC6A4 (0.57) SLC6A4SLC6A2HTR2AHRH1HTR2B
SCHEMBL27600867 0.72 SLC6A4 (0.52) SLC6A4SLC6A2HTR2AHRH1HTR2B
SCHEMBL1350229 0.71 MEN1 (0.56) MEN1KMT2ACYP19A1TSHRMAPK1
SCHEMBL27666403 0.71 SLC6A4 (0.55) SLC6A4SLC6A2HTR2AHRH1HTR2B
SCHEMBL73498 0.71 SLC6A4 (0.67) SLC6A4SLC6A2HTR2AHRH1HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109715595-B Process for preparing cyclopropyl substituted acetophenones 拜耳作物科学股份公司 2022-03-11 CN disclosed
EP-3523270-B1 VERFAHREN ZUR HERSTELLUNG VON CYCLOPROPYL-SUBSTITUIERTEN ACETOPHENONEN BAYER CROPSCIENCE AG (DE) 2020-10-21 EP disclosed
US-10633321-B2 Method for producing cyclopropyl-substituted acetophenones BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-04-28 US disclosed
EP-3523270-A1 METHOD FOR PRODUCING CYCLOPROPYL-SUBSTITUTED ACETOPHENONES Bayer CropScience Aktiengesellschaft (DE) 2019-08-14 EP disclosed
CN-109715595-A The method for preparing the acetophenone that cyclopropyl replaces 拜耳作物科学股份公司 2019-05-03 CN disclosed
CN-102603508-B Preparation method of 1-(4-chlorophenyl)-2-cyclopropyl-1-acetone and intermediate thereof as well as preparation method of intermediate JIANGSU CHENGYANG CROP TECHNOLOGY CO LTD 2014-03-12 CN disclosed
CN-102603508-A Preparation method of 1-(4-chlorophenyl)-2-cyclopropyl-1-acetone and intermediate thereof as well as preparation method of intermediate JIANGSU CHENGYANG CROP TECHNOLOGY CO LTD 2012-07-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10633321-B2 Method for producing cyclopropyl-substituted acetophenones CYP21A2, CYP17A1, HSD17B7 SLC6A4 1834/4885SLC6A2 2619/4885HTR2A 3900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.